IMPDH2 and Dystonia: Recent studies have identified mutations in inosine 5′ monophosphate dehydrogenase (IMPDH) 2, a key regulatory enzyme in purine nucleotide biosynthesis, associated with dystonia and other neurodevelopmental disorders.